Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort
癌症预防研究 3 队列中的环境化学物质负担和潜在乳腺癌风险
基本信息
- 批准号:10669253
- 负责人:
- 金额:$ 65.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-20 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAccelerationAddressAge YearsAgingAmerican Cancer SocietyAnimalsBiologicalBloodBlood BanksBlood specimenBody BurdenBreastBreast Cancer Risk FactorBreast Cancer cell lineBreast Epithelial CellsCancer ControlCancer EtiologyCarcinogenicity TestsCase/Control StudiesCellsChemical ExposureChemicalsCytokeratinDNA MethylationDataDevelopmentDiagnosisEndocrineEndocrine DisruptorsEnrollmentEnvironmental ExposureEnvironmental PollutantsEpithelial CellsEpitheliumEtiologyExposure toFemaleFoundationsFutureGenetic TranscriptionGenomeGenomicsGoalsHealthHormonesHumanLinkMalignant NeoplasmsMammary NeoplasmsMammary glandMeasurementMeasuresMethodologyMethylationMolecularMusMyoepithelial cellOutcomeParticipantPerimenopausePlasmaPoly-fluoroalkyl substancesPredispositionPrevention strategyProspective StudiesProteinsResearchResearch Project GrantsRiskRisk FactorsRoleSamplingSeminalSystemTestingTissuesUnited States Environmental Protection AgencyWomanWorkage relatedagedbead chipbreast cancer diagnosiscancer diagnosiscancer initiationcancer preventioncancer riskcancer subtypescarcinogenicitycase controlcohortdesignenvironmental chemicalepidemiology studyepigenome-wide association studiesin vivoinnovationinsightinterdisciplinary approachinterestmalignant breast neoplasmmammarymammary epitheliummethylomemultidisciplinarypolybrominated diphenyl etherprospectivestem cells
项目摘要
Today there are more than 85,000 EPA-registered synthetic chemicals, but only 10% have been tested for
carcinogenicity in animal studies. Of those tested, ~200 have shown evidence of causing cancer and/or an
increase in mammary tumors. However, few of the chemicals have been evaluated in human studies, and results
in humans have been inconclusive. Our study will focus on chemical body burden of per- and poly-fluoroalkyl
substances (PFAS), and concomitant risk of developing invasive breast cancer during the menopausal transition.
These “forever chemicals” are pervasive, enduring, and of high public interest, yet studies of their possible
relationship to breast cancer have been limited. We hypothesize that elevated body-burden levels of these
endocrine-disrupting chemicals (EDCs) will increase the risk of developing invasive breast cancer, and that
alterations in DNA methylation (DNAm) and the breast microenvironment are mechanisms that link these
chemical exposures and breast cancer. We will test this hypothesis using a three-pronged approach. In Specific
Aim 1, we will conduct a prospective study of women in the American Cancer Society Cancer Prevention Study-3
(CPS-3) to assess the association between body burden of PFAS during the menopausal transition and
subsequent development of invasive breast cancer. We will measure PFAS levels in plasma samples collected
1 to 7 years before invasive breast cancer diagnosis in 1000 CPS-3 participants and 1000 matched, cancer-free
CPS-3 participants, all between 40 and 57 years of age at blood draw. In Specific Aim 2, studying the same
participants, we will measure DNAm using Infinium MethylationEPIC BeadChips and conduct an epigenome-
wide association study (EWAS) to identify DNAm changes associated with levels of PFAS in the cancer-free
participants. We then will determine the association between the PFAS-associated DNAm changes and risk of
developing breast cancer. This valuable DNAm data also can be used later for other outcomes, including
exposure to other EDCs. In Specific Aim 3, we will determine the direct effects of PFAS on tissue- and molecular-
level states associated with susceptibility to cancer initiation in genomically-well-characterized primary human
breast mammary epithelial cells (HMECs). Identifying these mechanisms in primary breast cells is critically
important, as PFAS mechanisms of action generally differ by tissue. We will use 2-D cultures to determine the
effects of short-term exposures and 3-D cultures to define the effects of protracted chemical exposures on
changes in epithelial lineage consistent with accelerated aging and age-related molecular changes in genome
methylation, lineage-specific transcription, and cytokeratin proteins. Results from this multi-disciplinary approach
will advance our understanding of the effects of PFAS exposures on risk of developing breast cancer during an
important window of susceptibility. Ultimately, we hope results from our proposed project will identify an
integrated biological signature of environmental exposure, deliver mechanistic insights into breast cancer
development from EDCs, and inform future studies for prevention strategies to reduce or mitigate exposures.
今天,有超过8.5万种在EPA注册的合成化学品,但只有10%进行了测试
动物研究中的致癌性。在接受检测的人中,约有200人显示出致癌和/或
乳腺肿瘤增多。然而,很少有化学物质在人体研究中得到评估,结果是
对人类的影响一直没有定论。我们的研究将集中在全氟烷基和多氟烷基的化学体内负荷
在绝经过渡期间发生浸润性乳腺癌的风险。
这些“永恒的化学物质”无处不在、经久不衰,并具有很高的公众利益,但对其可能性的研究
与乳腺癌的关系一直有限。我们假设,这些人的身体负担水平升高
内分泌干扰物(EDCs)会增加患浸润性乳腺癌的风险,
DNA甲基化(DNaM)和乳房微环境的改变是将这些联系起来的机制
接触化学物质和乳腺癌。我们将使用三管齐下的方法来检验这一假设。具体而言
目标1,我们将对美国癌症协会癌症预防研究中的女性进行一项前瞻性研究
(CPS-3)评估绝经过渡期间全氟辛烷磺酸的身体负担与
随后发展为浸润性乳腺癌。我们将测量采集的血浆样本中的全氟辛烷磺酸水平
1000名CPS-3参与者和1000名匹配的无癌患者在浸润性乳腺癌诊断前1至7年
CPS-3参与者,抽血时年龄均在40岁至57岁之间。在具体目标2中,研究相同
参赛者,我们将使用InfiniumMegylationEPIC BeadChips测量dNaM,并进行表观基因组-
广泛关联研究(EWAS)以确定无癌人群中dNaM的变化与PFAS水平相关
参与者。然后,我们将确定与PFAS相关的dNaM变化与
罹患乳腺癌。这些有价值的dNaM数据还可以在以后用于其他结果,包括
暴露于其他EDC。在具体目标3中,我们将确定全氟辛烷磺酸对组织和分子的直接影响。
基因组特征良好的原发人类中与癌症起始易感性相关的水平状态
乳腺上皮细胞(HMECs)。在原代乳腺细胞中识别这些机制至关重要。
这一点很重要,因为全氟辛烷磺酸的作用机制通常因组织而异。我们将使用2-D培养来确定
短期暴露和3-D培养的影响,以确定长期化学暴露对
上皮谱系的变化与加速衰老和基因组中与年龄相关的分子变化相一致
甲基化、谱系特异性转录和细胞角蛋白。这种多学科方法的结果
将促进我们对接触PFAS对患乳腺癌风险的影响的理解
重要的易感窗口。最终,我们希望我们提议的项目的结果将确定一个
环境暴露的综合生物学特征,提供对乳腺癌的机械性见解
来自EDC的发展,并为减少或减轻暴露的预防战略的未来研究提供信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susan L. Neuhausen其他文献
Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variant
BRCA1 致病性变异女性的奇偶性、母乳喂养与早发性乳腺癌风险
- DOI:
10.1038/s41416-025-03029-x - 发表时间:
2025-05-02 - 期刊:
- 影响因子:6.800
- 作者:
Joanne Kotsopoulos;Christopher A. Maxwell;Jan Lubinski;Tomasz Huzarski;Raymond H. Kim;Nadine Tung;Andrea Eisen;William Foulkes;Amber Aeilts;Susan L. Neuhausen;Louise Bordeleau;Rama Khokha;Tuya Pal;Beth Karlan;Robert Fruscio;Fergus Couch;Ping Sun;Jacek Gronwald;Steven A. Narod - 通讯作者:
Steven A. Narod
Contraceptive use and the risk of ovarian cancer among women with a emBRCA1/em or emBRCA2/em mutation
- DOI:
10.1016/j.ygyno.2022.01.014 - 发表时间:
2022-03-01 - 期刊:
- 影响因子:4.100
- 作者:
Yue Yin Xia;Jacek Gronwald;Beth Karlan;Jan Lubinski;Jeanna M. McCuaig;Jennifer Brooks;Pal Moller;Andrea Eisen;Sophie Sun;Leigha Senter;Louise Bordeleau;Susan L. Neuhausen;Christian F. Singer;Nadine Tung;William D. Foulkes;Ping Sun;Steven A. Narod;Joanne Kotsopoulos;Rinat Yerushalmi;Robert Fruscio;Stephanie Cohen - 通讯作者:
Stephanie Cohen
Susan L. Neuhausen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susan L. Neuhausen', 18)}}的其他基金
Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort
癌症预防研究 3 队列中的环境化学物质负担和潜在乳腺癌风险
- 批准号:
10525499 - 财政年份:2022
- 资助金额:
$ 65.67万 - 项目类别:
Germline and Tumor Genomic Analyses of Breast Cancer in Latinas
拉丁裔乳腺癌的种系和肿瘤基因组分析
- 批准号:
8673705 - 财政年份:2014
- 资助金额:
$ 65.67万 - 项目类别:
Celiac Disease: From Genetic Risk to Disease Development
乳糜泻:从遗传风险到疾病发展
- 批准号:
7591126 - 财政年份:2008
- 资助金额:
$ 65.67万 - 项目类别:
Celiac Disease: From Genetic Risk to Disease Development
乳糜泻:从遗传风险到疾病发展
- 批准号:
8068619 - 财政年份:2008
- 资助金额:
$ 65.67万 - 项目类别:
Celiac Disease: From Genetic Risk to Disease Development
乳糜泻:从遗传风险到疾病发展
- 批准号:
7371748 - 财政年份:2008
- 资助金额:
$ 65.67万 - 项目类别:
The IGF Signaling Pathway and Breast Cancer Risk
IGF 信号通路与乳腺癌风险
- 批准号:
7579023 - 财政年份:2007
- 资助金额:
$ 65.67万 - 项目类别:
The IGF Signaling Pathway and Breast Cancer Risk
IGF 信号通路与乳腺癌风险
- 批准号:
7777345 - 财政年份:2007
- 资助金额:
$ 65.67万 - 项目类别:
The IGF Signaling Pathway and Breast Cancer Risk
IGF 信号通路与乳腺癌风险
- 批准号:
7373525 - 财政年份:2007
- 资助金额:
$ 65.67万 - 项目类别:
The IGF Signaling Pathway and Breast Cancer Risk
IGF 信号通路与乳腺癌风险
- 批准号:
7213798 - 财政年份:2007
- 资助金额:
$ 65.67万 - 项目类别:
GENETIC EPIDEMIOLOGY OF BREAST CANCER--BRCA1 AND BRCA2
乳腺癌的遗传流行病学--BRCA1和BRCA2
- 批准号:
6164238 - 财政年份:1998
- 资助金额:
$ 65.67万 - 项目类别:
相似海外基金
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
- 批准号:
NE/Y000080/1 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Research Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328975 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Continuing Grant
SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
- 批准号:
2400967 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328973 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Continuing Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
- 批准号:
10112700 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328972 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328974 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332916 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332917 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Standard Grant
Study of the Particle Acceleration and Transport in PWN through X-ray Spectro-polarimetry and GeV Gamma-ray Observtions
通过 X 射线光谱偏振法和 GeV 伽马射线观测研究 PWN 中的粒子加速和输运
- 批准号:
23H01186 - 财政年份:2023
- 资助金额:
$ 65.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B)